TAMs can be grouped in two major categories: 1) CD163- M1 macrophages, which are pro-inflammatory and 2) CD163+ M2 macrophages that are anti-inflammatory and are preferentially recruited at the tumor site (Figure 2). This evidence concerns the gene CD163 and neoplasm.